(19)

(11)

EP 1 144 630 A3

(12)

(88) Date of publication A3: 25.10.2001 (43) Date of publication A2: 17.10.2001 Bulletin 2001/42 (21) Application number: 99946611.3 (22) Date of filing: 19.08.1999

(51) International Patent Classification (IPC)7: C12N 15/12, C07K 14/475, A61K 38/18, C07K 16/22, C12N 15/11, C12Q 1/68, G01N 33/566 (86) International application number: PCT/US9919/072 (87) International publication number: WO 0011/169 (02.03.2000 Gazette 2000/09)

(84) Designated Contracting States: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE Designated Extension States: AL LT LV MK RO SI (30) Priority: 21.08.1998 US 150689 P 21.08.1998 US 137578 (71) Applicant: INCYTE PHARMACEUTICALS, INC. Palo Alto, CA 94304 (US)	(72) Inventors: TANG, Y., Tom San Jose, CA 95118 (US) CORLEY, Neil, C. Mountain View, CA 94040 (US) PATTERSON, Chandra Menlo Park, CA 94025 (US) GUEGLER, Karl, J. Menlo Park, CA 94025 (US) BAUGHN, Mariah, R. San Leandro, CA 94577 (US) (74) Representative: Wright, Simon Mark  J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ London WC1R 5JJ (GB)
	Remarks: WIPO A3 publication data is not currently available.